NeuroBo Pharmaceuticals, Inc.
NeuroBo Pharmaceuticals, Inc. (NRBO) is a publicly traded company in the Unknown sector. Across all available filings, 13 corporate insiders have executed 36 transactions totaling $18.0M, demonstrating a bullish sentiment with $18.0M in net insider flow. The most recent transaction on Sep 12, 2024 involved a sale of 407 shares valued at $1.5K.
NRBO Insider Activity Summary
Who Is Buying NRBO Stock?
No significant insider buying has been recorded for NRBO in the recent period.
Who Is Selling NRBO Stock?
No significant insider selling has been recorded for NRBO in the recent period.
Is NeuroBo Pharmaceuticals, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for NRBO is bullish with an Insider Alignment Score of 100/100 and a net flow of $18.0M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
NRBO Frequently Asked Questions
Understanding NRBO Insider Activity
Insider trading at NeuroBo Pharmaceuticals, Inc. (NRBO) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 13 insiders are actively trading NRBO stock, having executed 36 transactions in the past 90 days. The most active insider is St Co., Ltd Dong-a (Executive), who has made 3 transactions totaling $18.0M.
Related Tools
Track NeuroBo Pharmaceuticals, Inc. Insider Activity
Get notified when executives and directors at NRBO file new Form 4 transactions